Latest close
$89.74
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Pabrai Investments | 43.32% | 1,744,050 | TRIMMED (-3.7%) |
| Third Avenue Management | 3.70% | 285,398 | TRIMMED (-21.6%) |
| First Eagle Investment Management | 0.52% | 3,879,058 | NEW |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 4 sales by 3 insiders ($11.6M).
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).
Financial Screens
· Graham — Sound finances and a long run of profits
· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Key figures
· Graham — Current ratio: 3.19 · Straight profitable years: 5 · Debt ratio: 0.30 · Latest net income: $57.0M
· Cash Flow (FCF) — Latest FCF: $636.7M · FCF yield: 13.5% · Positive FCF years: 3
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.32 · Operating cash flow: $229.2M · Net income: $57.0M
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.